Severe Migraine Treatment with Dosing
For severe migraine attacks, initiate combination therapy with a triptan plus an NSAID or acetaminophen as first-line treatment, using specific doses such as sumatriptan 50-100 mg with naproxen sodium 550 mg or ibuprofen 400-800 mg, taken as early as possible in the attack. 1
Acute Treatment Algorithm for Severe Migraine
First-Line: Combination Therapy
The most recent and highest-quality evidence from the 2025 American College of Physicians guideline establishes combination therapy as superior to monotherapy for moderate-to-severe migraine 1. Start treatment immediately at headache onset—early administration is critical for efficacy.
Recommended Combinations:
- Sumatriptan 50-100 mg + Naproxen sodium 550 mg 2, 1
- Any triptan + Ibuprofen 400-800 mg 1
- Rizatriptan 5-20 mg + NSAID (maximum 30 mg/day rizatriptan) 2
- Zolmitriptan 2.5-5 mg + NSAID 2
The combination approach provides faster pain relief, higher rates of pain freedom at 2 hours, and reduced headache recurrence compared to either medication alone 3, 1.
Alternative Triptan Options and Dosing
If oral route is compromised by severe nausea/vomiting:
- Sumatriptan subcutaneous: 6 mg (can repeat in 1 hour; maximum 12 mg/24 hours) 2
- Sumatriptan intranasal: 5-10 mg (one to two sprays; can repeat after 2 hours; maximum 40 mg/day) 2
- Zolmitriptan nasal spray 2
- Rizatriptan orally disintegrating tablet (Maxalt MLT) 2
Second-Line Options (If Combination Therapy Fails)
CGRP Antagonists (Gepants):
These are recommended when patients don't tolerate or have inadequate response to triptan-NSAID combinations 1. Evidence quality is lower than for triptans, but they offer an alternative mechanism without vasoconstriction.
Third-Line: Lasmiditan (Ditan)
Lasmiditan should be reserved for patients who fail all other treatments 1. Critical warning: Patients cannot drive or operate machinery for at least 8 hours after taking lasmiditan due to CNS effects including dizziness and driving impairment 3.
Adjunctive Therapy for Nausea/Vomiting
Add prokinetic antiemetics 20-30 minutes before or with acute medications 3, 2:
- Metoclopramide 10 mg IV or oral 2
- Prochlorperazine 25 mg oral or suppository (maximum 3 doses/24 hours) 2
- Domperidone 3
These improve gastric motility (impaired during migraine) and provide synergistic analgesia 2.
Critical Medications to AVOID
Never use for severe migraine: 3, 1
- Opioids (meperidine, hydromorphone, morphine) - questionable efficacy, high risk of dependency, medication overuse headache, and eventual loss of efficacy
- Butalbital-containing analgesics - same concerns as opioids
- Oral ergot alkaloids - poorly effective and potentially toxic
The 2025 ACP guideline explicitly states "Do not use opioids or butalbital" 1, and the 2021 Nature Reviews guideline emphasizes these "should be avoided" 3.
Dosing Principles and Pitfalls
Medication Overuse Headache (MOH) Thresholds
Monitor frequency carefully to prevent MOH 1:
- Triptans: ≥10 days per month triggers MOH risk
- NSAIDs: ≥15 days per month triggers MOH risk
- Combination analgesics: ≥10 days per month
Trial-and-Error Within Drug Classes
If one triptan fails, try a different triptan before abandoning the class 2, 4. Patients should trial a medication for 2-3 headache episodes before determining inefficacy 2. Individual response varies significantly between triptans despite similar mechanisms.
Specific NSAID Dosing for Severe Migraine
- Ibuprofen: 400-800 mg every 6 hours (maximum 2.4 g/day) 2
- Naproxen sodium: 550 mg every 2-6 hours (maximum 1.5 g/day) 2
- Diclofenac potassium 3
- Aspirin: 650-1000 mg every 4-6 hours (maximum 4 g/day) 2
When to Consider Preventive Therapy
If severe migraines occur frequently despite optimized acute treatment, initiate preventive therapy 3. Indications include:
- ≥2 disabling migraine days per month despite acute treatment
- Overuse of acute medications approaching MOH thresholds
- Attacks lasting >12 hours despite treatment
- Significant migraine-related disability affecting quality of life
First-line preventive options include topiramate, valproate, propranolol, metoprolol, or CGRP monoclonal antibodies, with efficacy assessed after 2-3 months for oral medications or 3-6 months for CGRP antibodies 3, 5.
Special Populations
Pregnancy: Acetaminophen is safest; sumatriptan may be considered in selected patients 6. Avoid NSAIDs in third trimester and valproate entirely.
Cardiovascular contraindications: Use NSAIDs, acetaminophen, gepants, or dopamine antagonists instead of triptans or ergots 6.